Devuyst G, Bogousslavsky J
University Department of Neurology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Curr Opin Neurol. 1999 Feb;12(1):73-9. doi: 10.1097/00019052-199902000-00012.
One of the most recent advances and hopes in stroke therapy concerns neuroprotection, which has recently been investigated in several clinical trials. Furthermore, some new neuroprotective drugs, which are based on newly identified cellular and molecular mechanisms that underlie the development of focal ischaemic injury, will be tested in stroke patients in the future. It must be emphasized, however, that the concept and application of neuroprotection must remain within the frame of the global network and organization of acute stroke care, because neuroprotection at best may become only a link among many other management strategies for acute stroke.
中风治疗领域最新的进展与希望之一涉及神经保护，最近已有多项临床试验对其展开研究。此外，一些基于新发现的局灶性缺血性损伤发生发展所涉及的细胞和分子机制的新型神经保护药物，未来将在中风患者身上进行试验。然而，必须强调的是，神经保护的概念与应用必须处于急性中风护理的全球网络和组织框架之内，因为神经保护充其量可能只是急性中风众多管理策略中的一个环节。
